Open Access
Performance standards for antimicrobial susceptibility testing
Reads0
Chats0
TLDR
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.Abstract:
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition. The standards contain information about both disk (M02) and dilution (M07 and M11) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and QC using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the previous edition appear in boldface type.) Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2016. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition are followed.read more
Citations
More filters
Journal ArticleDOI
Identification of FDA-Approved Drugs and Bioactives that Protect Hair Cells in the Zebrafish (Danio rerio) Lateral Line and Mouse (Mus musculus) Utricle
Henry C. Ou,Henry C. Ou,Lisa L. Cunningham,Shimon P. Francis,Carlene Brandon,Julian A. Simon,David W. Raible,Edwin W. Rubel +7 more
TL;DR: The results demonstrate that the zebrafish lateral line can be used to screen successfully for drugs within a library of FDA-approved drugs and bioactives that inhibit hair cell death in the mammalian inner ear and identify tacrine as a promising protective drug for future studies.
Journal ArticleDOI
Genotypes, exotoxin gene content, and antimicrobial resistance of Staphylococcus aureus strains recovered from foods and food handlers.
M. A. Argudín,M. C. Mendoza,M. A. González-Hevia,Margarita Bances,Beatriz Guerra,M. R. Rodicio +5 more
TL;DR: The presence of S. aureus strains with an important repertoire of virulence and resistance determinants in the food chain represents a potential health hazard for consumers and merits further observation.
Journal ArticleDOI
Role of ISKpn7 and Deletions in blaKPC Gene Expression
TL;DR: Using 5′ rapid amplification of cDNA ends (5′RACE), the authors identified three potential promoter sequences (P1, P2, and P3) upstream of the bla KPC gene, of which only P1 (absent from isoforms c and d ) and P2 (present in all isoforms, with a −35 box located inside the right inverted repeat of IS Kpn7 ) were shown to be true promoters involved in expression.
Journal ArticleDOI
Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens
TL;DR: The in vitro activity of daptomycin against 224 current gram-positive clinical isolates including vancomycin-resistantEnterococcus faecium (VREF), methicillin-resistantStaphylococcus aureus (MRSA, MRSS, and penicillin -resistantStreptococcus pneumoniae (PRSP) was evaluated.
Journal ArticleDOI
Prevalence of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Food-Producing Animals
Midori Hiroi,Fumie Yamazaki,Tetsuya Harada,Naomi Takahashi,Natsuko Iida,Yoshihiro Noda,Miya Yagi,Tomohiro Nishio,Takashi Kanda,Fumihiko Kawamori,Kanji Sugiyama,Takashi Masuda,Yukiko Hara-Kudo,Norio Ohashi +13 more
TL;DR: Evidence is provided that the proliferation of CTX-M-producing E. coli is due to the growth of indigenous CTX,M- producing strains and the possible emergence of strains that acquired CTx-M genes by horizontal transfer in different broiler farms, which should be controlled.